Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Myocardial Infarction and New Treatment With Metformin Study (MIMET) - a R-RCT to Study Metformin and the Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Newly Detected Prediabetes

NCT05182970 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT05182970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05182970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Myocardial Infarction and New Treatment With Metformin Study (MIMET) - a R-RCT to Study Metformin and the Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Newly Detected Prediabetes
Lead sponsor
Karolinska Institutet
Phase
Phase 3
Overall status
Unknown status
Start date
December 2, 2021
Completion date
May 31, 2026
Enrollment
5,160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, non st elevation myocardial infarction, prediabetes, st elevation myocardial infarction